Oncology

Oncology

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
41-60 of 232 ARTICLES
https://doi.org/10.12688/f1000research.75075.3
Case Report metrics
Revised
Case Report: Placental site trophoblastic tumor revealed by a clinical pelvic abscess
[version 3; peer review: 1 approved, 2 approved with reservations, 1 not approved]
Peer Reviewers Antonio Braga; Maria-Gabriela Aniţei; Guglielmo Stabile; Seetu Palo
LATEST VERSION PUBLISHED 21 Oct 2024
https://doi.org/10.12688/f1000research.156203.1
Study Protocol metrics AWAITING PEER REVIEW
Clinical trial
Effect of lycopene on prostate cancer among native African men: A protocol for an open-label randomized clinical trial in Tanzania
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
  • Funder
  • Ministry of Health Republic of Uganda
PUBLISHED 02 Oct 2024
https://doi.org/10.12688/f1000research.25457.2
Study Protocol metrics
Revised
Protocol for a mixed-methods exploratory investigation into the role of health information technology for the provision of cancer care in Indonesia
[version 2; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Niloofar Mohammadzadeh; Andree Kurniawan
  • Funder
  • Research England
LATEST VERSION PUBLISHED 24 Sep 2024
https://doi.org/10.12688/f1000research.143642.5
Research Article metrics
Revised
Metabolomic characterization of human glioblastomas and patient plasma: a pilot study
[version 5; peer review: 2 approved]
Peer Reviewers Joseph Chen; Andrew J Scott
  • Funders
  • Career development award from the Dean’s Office of the UC Davis School of Medicine
  • National Cancer Institute
  • Academic Senate Large Grant
LATEST VERSION PUBLISHED 19 Sep 2024
https://doi.org/10.12688/f1000research.153724.1
Research Article metrics AWAITING PEER REVIEW
Heart of Care: Embracing Grief and Growth in Oncology and Palliative Medicine
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
PUBLISHED 18 Sep 2024
https://doi.org/10.12688/f1000research.132031.2
Review metrics
Revised
Anticancer activities of tocotrienols: A Systematic Scoping Review
[version 2; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Kok Lun Pang; Gloria López
LATEST VERSION PUBLISHED 16 Aug 2024
https://doi.org/10.12688/f1000research.132524.2
Research Article metrics
Revised
Proteomics analysis of carcinogenesis in a rat model of mammary cancer induced by DMBA (7,12-dimethylbenz[a]anthracene)
[version 2; peer review: 3 approved]
Peer Reviewers Muhammad Luqman Nordin; Hevi Wihadmadyatami; Jasni Bin Sabri
  • Funder
  • Universitas Brawijaya
LATEST VERSION PUBLISHED 05 Aug 2024
https://doi.org/10.12688/f1000research.134946.3
Case Report metrics
Revised
Case Report: Activated B-cell-diffuse large B-cell lymphoma
[version 3; peer review: 3 approved, 1 approved with reservations]
Peer Reviewers Junn-Liang Chang; Soundarya Ravi; Puneeta Vohra; Dr. Akshay Dhobley
LATEST VERSION PUBLISHED 02 Aug 2024
https://doi.org/10.12688/f1000research.73076.3
Research Article metrics
Revised
New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirin
[version 3; peer review: 3 not approved]
Peer Reviewers Asmaa Gomaa; Chia-Yen Dai; William L Irving
LATEST VERSION PUBLISHED 03 Jul 2024
https://doi.org/10.12688/f1000research.131013.2
Research Article metrics
Revised
Unraveling the molecular mechanism of novel leukemia mutations on NTRK2 (A203T & R458G) and NTRK3 (E176D & L449F) genes using molecular dynamics simulations approach
[version 2; peer review: 3 approved]
Peer Reviewers Dicson Sheeja Malar; Gurudeeban Selvaraj; Rajasekaran R.
  • Funder
  • This work was primarily supported by grants from the Deanship of Scientific Research, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
LATEST VERSION PUBLISHED 18 Jun 2024
https://doi.org/10.12688/f1000research.136087.2
Brief Report metrics
Revised
Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition
[version 2; peer review: 2 approved]
Peer Reviewers Konstantinos Kamposioras; Athanasia Pavlopoulou
  • Funder
  • European Union and Greek national funds, Operational Program Competitiveness, Entrepreneurship and Innovation, under RESEARCH—CREATE—INNOVATE
LATEST VERSION PUBLISHED 14 Jun 2024
https://doi.org/10.12688/f1000research.133862.2
Research Article metrics
Revised
Prognostic role of tumor budding in oral squamous cell carcinoma: a retrospective study
[version 2; peer review: 1 approved]
Peer Reviewers Devendra Palve
LATEST VERSION PUBLISHED 12 Jun 2024
https://doi.org/10.12688/f1000research.138780.2
Case Report metrics
Revised
Case Report: Sebaceous carcinoma of the eyelid
[version 2; peer review: 1 approved with reservations, 1 not approved]
Peer Reviewers Jianmin Ma; Vijitha S Vempuluru
LATEST VERSION PUBLISHED 12 Jun 2024
https://doi.org/10.12688/f1000research.134992.3
Systematic Review metrics
Revised
Association between eNOS rs1799983 (894G>T) Polymorphism with Cancer and Stroke Risk: A meta-analysis
[version 3; peer review: 1 approved with reservations, 3 not approved]
Peer Reviewers Eric Tzyy Jiann Chong; Katrina Miranda; Mirza Saqib Baig; Saori Furuta
  • Funder
  • Lembaga Penelitian dan Inovasi Universitas Airlangga
LATEST VERSION PUBLISHED 10 Jun 2024
https://doi.org/10.12688/f1000research.134757.2
Study Protocol metrics
Revised
Protocol for correlation of histological risk assessment/scoring system with a depth of invasion in oral squamous cell carcinoma
[version 2; peer review: 2 approved]
Peer Reviewers Alessandro Polizzi; Jose A. Hardillo
LATEST VERSION PUBLISHED 31 May 2024
https://doi.org/10.12688/f1000research.127691.2
Research Article metrics
Revised
Breast cancer related physical, psychological, social and spiritual domains of quality of life among women in Bahrain
[version 2; peer review: 1 approved, 2 not approved]
Peer Reviewers Salwa Hagag Abdelaziz; Chung-Ying Lin; Tharin Phenwan
LATEST VERSION PUBLISHED 28 May 2024
https://doi.org/10.12688/f1000research.132627.3
Research Article metrics
Revised
Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma
[version 3; peer review: 1 approved, 2 approved with reservations, 1 not approved]
Peer Reviewers Griffith D Parks; Estanislao Nistal-Villan and Vicent Tur-Planells; Thomas C. N. Leung; Monica Martinez Pacheco
  • Funders
  • Rosetrees Trust
  • Neuroblastoma UK
  • Medical Research Council
  • Children's Cancer and Leukaemia Group
  • Wessex Medical Research
LATEST VERSION PUBLISHED 21 May 2024
https://doi.org/10.12688/f1000research.148984.1
Case Report metrics
Case Report: Urothelial urethral carcinoma in HIV patient underwent total urethrectomy and perineal urethrostomy
[version 1; peer review: 1 approved]
Peer Reviewers Pande Made Wisnu Tirtayasa
PUBLISHED 08 May 2024
https://doi.org/10.12688/f1000research.145493.2
Review metrics
Revised
Hepatocellular carcinoma: Advances in systemic therapies
[version 2; peer review: 3 approved]
Peer Reviewers Won-Mook Choi; Shang-Chin Huang; Leonardo Stella
LATEST VERSION PUBLISHED 07 May 2024
https://doi.org/10.12688/f1000research.148756.1
Research Article metrics
CD24 and Oct4: Cancer stem markers expression correlates with histological subtyping of head and neck squamous cell carcinoma
[version 1; peer review: 1 approved with reservations]
Peer Reviewers V K Varsha
  • Funder
  • University of Health Sciences Lahore
PUBLISHED 23 Apr 2024
41-60 of 232 ARTICLES
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.